NBG
GILD icon

Nancy B. Gardiner’s Gilead Sciences GILD Stock Holding History

Nancy B. Gardiner’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,895
Closed -$396K – 50
2017
Q3 		$396K Sell
4,895
-195
-4% -$14.9K 0.73% 38
2017
Q2 		$360K Buy
5,090
+400
+9% +$26.6K 0.73% 39
2017
Q1 		$319K Buy
4,690
+381
+9% +$26.8K 0.74% 41
2016
Q4 		$308K Sell
4,309
-504
-10% -$37.5K 0.78% 43
2016
Q3 		$380K Buy
4,813
+2,297
+91% +$187K 0.97% 37
2016
Q2 		$209K Buy
+2,516
New +$223K 0.67% 52

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nancy B. Gardiner's GILD Position: Q4 2017 in Review

Nancy B. Gardiner sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 4,895 shares — an estimated $396K sold.

Nancy B. Gardiner first reported a position in GILD in Q2 2016 and held it in 6 quarters. The position peaked at $396K in Q3 2017. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Nancy B. Gardiner reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Nancy B. Gardiner sold 4,895 Gilead Sciences shares in Q4 2017, an estimated $396K.
  • Nancy B. Gardiner first reported a position in Gilead Sciences in Q2 2016 and held it in 6 quarters.
  • Nancy B. Gardiner's Gilead Sciences position peaked at $396K in Q3 2017.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Nancy B. Gardiner's 13F filing for Q4 2017, filed 2 Feb 2018.